Mountain View, CANCT06664502Now EnrollingIRB Ready

Macular Degeneration Clinical Trial in Mountain View, CA

Access cutting-edge macular degeneration treatment through this clinical trial at a research site in Mountain View. Study-provided care at no cost to qualified participants.

Sponsored by EyeBiotech Ltd.

Quick Self-Assessment

See if you qualify for this Mountain View location

Preparing your pre-screening questions...

Expert Care in Mountain View

Access macular degeneration specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related macular degeneration treatment provided free

Apply for This Mountain View Location

Check if you qualify for this macular degeneration clinical trial in Mountain View, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Mountain View

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Mountain View site if eligible
  4. 4Begin participation

About This Macular Degeneration Study in Mountain View

EYE-TIE-201 is a 2-part study to investigate the safety and effectiveness of a new drug being developed called EYE201. All participants in the study will receive a total of 3 injections of EYE201 into the study eye, spaced at 4 weeks apart. In the first part, termed the multiple ascending dose (MAD) portion of study, the safety of EYE201 will be assessed at increasing doses in branch retinal vein occlusion (BRVO) participants. Approximately 12 participants will be entered in this part of the s

Sponsor: EyeBiotech Ltd.

Who Can Participate

Inclusion Criteria

Written informed consent before the first study-related activity
Be male or female ≥ 18 years of age
If female, have a negative serum pregnancy test at Screening and further negative urine tests immediately before each dose of study medication if the participant is a female of childbearing potential. General Key

Exclusion Criteria

Be pregnant or breastfeeding
Have a history of cataract surgery and/or minimally invasive glaucoma surgery in the study eye within 90 days of Screening
Have uncontrolled blood pressure, defined as systolic ≥180 mmHg and/or diastolic ≥100 mmHg while a participant is at rest.
Have had Yttrium-Aluminum Garnet laser capsulotomy in the study eye within 90 days of Screening
Have had Pan-retinal Photocoagulation or focal thermal laser photocoagulation in the study eye
Have tractional retinal detachment in the study eye
Have uncontrolled glaucoma (defined as IOP ≥ 25 mmHg despite treatment with antiglaucoma medica

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Mountain View?

Yes, this clinical trial (NCT06664502) has an active research site in Mountain View, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Macular Degeneration Treatment Options in Mountain View, CA

If you're searching for macular degeneration treatment options in Mountain View, CA, this clinical trial (NCT06664502) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Mountain View research site is actively enrolling participants for this clinical trial. You'll receive care from experienced macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all macular degeneration clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Mountain View, CA

See all rheumatoid arthritis clinical trials recruiting in Mountain View — not just this study.

Browse Rheumatoid Arthritis Trials in Mountain View

Ready to Join in Mountain View?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Mountain View, CA